Home

Genetic Cancer Risk in the Young (RisC) study

RiSC was one of Omico's research programs investigating the genetic variants that contribute to inherited cancer risk. Recruitment has now closed and follow-up research continues.

Participation process

About RisC

Recruitment to RiSC has now closed.

The information below describes the study and participation while recruitment was open.

The RiSC study aimed to understand more about the genetic variants that contribute to inherited cancers – understanding that is crucial for both cancer patients and their families.

We trust that this knowledge will lead to more personalised cancer treatments that result in better outcomes, improved cancer screening, increased options for reducing cancer risks and more fully informed lifestyle and reproductive decisions. The study also aims to assess the health-related costs.

Who can participate in RisC?

Recruitment has now closed.

The information below describes the eligibility criteria that applied while RiSC was open.

Patients (aged 16+ years) must have a histologically confirmed cancer and have:

  • One cancer diagnosis ≤ 40 years of age, or
  • Two cancer diagnoses ≤ 50 years of age, or
  • Multiple primary cancer diagnoses at any age (excluding BCC)

What does participation involve?

Recruitment has now closed.

The information below describes what participation involved while RiSC was open.

  • Discussing the study with the RisC team (via telephone or face-to-face)
  • Consenting to access of samples held by your pathology centres
  • Consenting to access to medical and similar records
  • Providing a blood sample
  • Supplying family history information
  • Completing questionnaires
  • Consenting to biobanking (optional)
  • Consenting to access to Medicare/PBS data (optional)

Interested in knowing more?

Get in touch